February 9, 2010
Star skier Jimmie Heuga dies – He helped thousands with MS to live their lives
- /
Vail Daily Heuga’s Vail Valley-based organization has helped thousands with multiple sclerosis live active lives Jimmie Heuga, the American skier…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
February 9, 2010
Multiple Sclerosis Experts Join Biogen Idec’s Research and Development Team
- /
CAMBRIDGE, Mass., Feb 08, 2010 (BUSINESS WIRE) — Biogen Idec a global biotechnology leader in the discovery, development, manufacturing and…
February 9, 2010
My Friend, “The Wheelchair Kamikaze” needs your vote
- /
- /
Wheelchair Kamikaze was nominated in a “Best Patient’s Blog” award contest being run by medgadget.com. Incredibly it’s become a two-way…
February 9, 2010
Oral drugs to treat multiple sclerosis could become available in 2011
- /
- /
Information provided by Odalys in Miami: with regards to Oral Cladribine and Fingolimod Oral drugs to treat multiple sclerosis could…
February 8, 2010
New Study Finds Specialized Support Programs Can Increase Treatment Adherence and Persistence, Reduce Relapses for People with Multiple Sclerosis
- /
Study Patients Also Reported Improved Ability to Manage Their Health Support Programs May Yield Cost Savings Press Release Source: UnitedHealth…
February 8, 2010
Multiple Sclerosis: Blacks Have More Severe Symptoms, Decline Faster Than Whites, New Study Shows
- /
February 8, 2010 Fewer African Americans than Caucasians develop multiple sclerosis (MS), statistics show, but their disease progresses more rapidly,…
February 8, 2010
Research on the Blood-Brain Barrier in MS
- /
- /
- /
What is the blood-brain-barrier? The blood-brain barrier (BBB) is a specialized structure formed by the blood vessels of the central…
February 6, 2010
Biogen Plans First Study For Earlier Use Of MS Drug Tysabri
- /
- /
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones) Biogen Idec Inc. (BIIB) is planning the first clinical…
February 5, 2010
AMPYRA for Multiple Sclerosis – Pricing that will benefit the MS Patient
- /
- /
- /
- /
Information found here was provided by Acorda Therapeutics February 5, 2010 The wholesale acquisition cost is $1,065 per 30-day supply…
February 5, 2010
FDA warns of brain risks with frequent Tysabri use
- /
- /
Yahoo Finance FDA finds connection between brain inflammation and frequent use of Tysabri On Friday February 5, 2010, 12:53 pm…
